Hemispherx BioPharma Inc. (HEB) dipped -5.4% or -0.03 to $0.47. It is approximately 327941 shares traded, which is 49.63% compare to the average total volume 660774. The market cap of HEB is $15.07 million. The year to date change is 44.93%. The 52 week price range is from $0.3 to $0.84. Price of HEB have changed 3.09% during last week. It have changed -2.72% over last month, 51.75% over last 3 months, 36.99% over last 6 months and 2.46% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for HEB is 0.45. It is -4.26% below current price. The 200-day Moving Averages for HEB is 0.42. It is -10.64% below current price. The 52-week High is 0.84. It is 78.72% from the current price. The 52-week Low is 0.3. It is -36.17% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of HEB is 2.87 on 2018-02-15. Short % to float is 6.65%. There are some statistics of HEB. It is has market cap $15.07 million. The share outstanding is 31.87 million. The average volume is 660774. The percent of top 15 Institution holding is 8.90%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of HEB is -55.78%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of HEB is -40.99%.